
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Human Ipsc-Derived Cardiomyocytes
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Discovery
Sponsor : Curi Bio
Deal Size : Undisclosed
Deal Type : Acquisition
Curi Bio Acquires Dana Solutions
Details : Through the acquisition, Curi will gain access to Dana’s AI/ML-based platforms including PhenoLearn™, a deep learning platform for modeling cell and tissue phenotypes; Pulse™, an automated platform for contractility analysis of beating cardiomyocyt...
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
July 23, 2020
Lead Product(s) : Human Ipsc-Derived Cardiomyocytes
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Discovery
Sponsor : Curi Bio
Deal Size : Undisclosed
Deal Type : Acquisition
